Cefpodoxime is a third generation oral cephalosporin antibiotic used to treat bacterial infections. It works by inhibiting bacterial cell wall synthesis through binding to penicillin binding proteins. This action prevents the formation of peptidoglycan crosslinks thereby weakening the bacterial cell wall. The drug is absorbed from the gastrointestinal tract and achieves systemic concentrations that reach therapeutic levels in tissues. Its pharmacokinetics involve partial metabolism in the liver and elimination primarily through the kidneys. Cefpodoxime is indicated for infections such as respiratory tract infections skin infections and urinary tract infections. The medication exerts its effect by disrupting cell wall integrity leading to bacterial lysis and death. The overall pharmacological profile supports its use as a broad spectrum antibiotic in clinical practice.

Cefpodoxime is a third-generation cephalosporin antibiotic used clinically to treat bacterial infections. Its molecular structure features a cephem core with a methoxyimino group that enhances resistance to many beta-lactamases. The drug functions by binding to penicillin-binding proteins in bacterial cell walls, thereby inhibiting peptidoglycan synthesis. This interference disrupts the formation of the bacterial cell wall, leading to osmotic instability and cell lysis. Cefpodoxime is administered orally or intravenously and possesses a favorable pharmacokinetic profile that supports its use in community-acquired infections. The medication exhibits activity against a broad spectrum of gram-positive and gram-negative organisms, making it suitable for respiratory and urinary tract infections. Its pharmacokinetic properties include high plasma protein binding and hepatic metabolism that prolongs its half-life, allowing once-daily dosing in many regimens. By targeting essential microbial processes, Cefpodoxime provides therapeutic benefit while maintaining a low potential for resistance development compared to older cephalosporins.

Common side effects of Cefpodoxime can include mild gastrointestinal discomfort such as nausea and diarrhea. Headache and dizziness are also reported in some individuals. Skin reactions like rash or itching may occur. Rarely elevated liver enzymes can be detected in blood tests. Allergic responses such as hives or facial swelling are infrequent. Fatigue or joint pain have been noted in certain patients.

Cefpodoxime is an oral antibiotic commonly used to treat bacterial infections. It may cause gastrointestinal symptoms such as nausea, abdominal pain, and diarrhea. Skin reactions like rash or itching can also occur in some patients. Headache, dizziness, and occasional fatigue are reported side effects. Allergic responses may include swelling of the lips or tongue in rare cases. These effects are generally mild and resolve without specific treatment. Any unexpected symptoms should be discussed with a healthcare professional